Role of calbindin-D28K in estrogen treatment for Parkinson's disease

被引：6
|
作者：
Wane, Chunhua [1 ,2 ,3 ]
Jiang, Chao [1 ]
Yuan, Honghua [1 ]
Xiao, Chenghua [2 ]
Gao, Dianshuai [1 ,2 ]
机构：
[1] Xuzhou Med Coll, Dept Neurobiol, Xuzhou 221002, Jiangsu, Peoples R China
[2] Xuzhou Med Coll, Dept Neurol, Xuzhou 221002, Jiangsu, Peoples R China
[3] Funing Cty Peoples Hosp, Dept Neurol, Yancheng 224400, Jiangsu, Peoples R China
来源：
NEURAL REGENERATION RESEARCH | 2013年 / 8卷 / 08期
关键词：
neural regeneration; neurodegenerative diseases; estrogen; calbindin-D28K; Parkinson's disease; dopaminergic neuron; tyrosine hydroxylase; photographs-containing paper; neuroregeneration; MPTP MOUSE MODEL; DOPAMINERGIC-NEURONS; SIGNALING PATHWAY; G-PROTEIN; ESTRADIOL; INVOLVEMENT; EXPRESSION; BINDING; KINASE; 17-BETA-ESTRADIOL;
D O I：
10.3969/j.issn.1673-5374.2013.08.004
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Studies have shown that estrogen has neuroprotective effects on the nigrostriatal system. The present study established a Parkinson's disease model in C57BL/6 mice by intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrapyridine. The mice were subjected to 17 beta estradiol injection into the lateral ventricle. Immunofluorescence double staining showed that estrogen increased tyrosine hydroxylase and calbindin-D28K expression and co-expression in dopaminergic neurons of midbrain substantia nigra pars compacta of model mice. Behavior experiments showed that estrogen improved swimming and hanging behaviors in this mouse model of Parkinson's disease.
引用
收藏
页码：702 / 707
页数：6
相关论文
共 50 条
  • [41] Intracellular calcium ion response to glucose in β-cells of calbindin-D28k nullmutant mice and in βHC13 cells overexpressing calbindin-D28k
    Parkash, J
    Chaudhry, MA
    Amer, AS
    Christakos, S
    Rhoten, WB
    ENDOCRINE, 2002, 18 (03) : 221 - 229
  • [42] DISTRIBUTION OF CALRETININ, CALBINDIN-D28K, AND PARVALBUMIN IN THE RAT THALAMUS
    ARAI, R
    JACOBOWITZ, DM
    DEURA, S
    BRAIN RESEARCH BULLETIN, 1994, 33 (05) : 595 - 614
  • [43] Functionally improved bone in Calbindin-D28k knockout mice
    Margolis, David S.
    Kim, Devin
    Szivek, John A.
    Lai, Li-Wen
    Lien, Yeong-Hau H.
    BONE, 2006, 39 (03) : 477 - 484
  • [44] CALBINDIN-D28K LOCALIZATION IN RAT MOLARS DURING ODONTOGENESIS
    ELMS, TN
    TAYLOR, AN
    JOURNAL OF DENTAL RESEARCH, 1987, 66 (09) : 1431 - 1434
  • [45] Calbindin-D28k in cortical regions of the lizard Psammodromus algirus
    Dávila, JC
    Padial, J
    Andreu, MJ
    Guirado, S
    JOURNAL OF COMPARATIVE NEUROLOGY, 1999, 405 (01) : 61 - 74
  • [46] Peptide binding proclivities of calcium loaded calbindin-D28k
    Kordys, David R.
    Bobay, Benjamin G.
    Thompson, Richele J.
    Venters, Ronald A.
    Cavanagh, John
    FEBS LETTERS, 2007, 581 (24) : 4778 - 4782
  • [47] ONTOGENY OF CALBINDIN-D28K AND CALBINDIN-D9K IN THE MOUSE KIDNEY, DUODENUM, CEREBELLUM AND PLACENTA
    SHAMLEY, DR
    OPPERMAN, LA
    BUFFENSTEIN, R
    ROSS, FP
    DEVELOPMENT, 1992, 116 (02): : 491 - 496
  • [48] Calbindin-D28k controls [Ca2+]i and insulin release -: Evidence obtained from calbindin-D28k knockout mice and β cell lines
    Sooy, K
    Schermerhorn, T
    Noda, M
    Surana, M
    Rhoten, WB
    Meyer, M
    Fleischer, N
    Sharp, GWG
    Christakos, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 34343 - 34349
  • [49] Intracellular calcium ion response to glucose in β-cells of calbindin-D28k nullmutant mice and in βHC13 cells overexpressing calbindin-D28k
    Jai Parkash
    Muhammad A. Chaudhry
    Ayman S. Amer
    Sylvia Christakos
    William B. Rhoten
    Endocrine, 2002, 18 : 221 - 229
  • [50] CALBINDIN-D28K AND PARVALBUMIN IMMUNOREACTIVITY IN THE RAT HIPPOCAMPUS FOLLOWING ADRENALECTOMY AND CORTICOSTERONE TREATMENT
    KRUGERS, HJ
    MEDEMA, RM
    POSTEMA, F
    KORF, J
    BRAIN CORTICOSTEROID RECEPTORS: STUDIES ON THE MECHANISM, FUNCTION, AND NEUROTOXICITY OF CORTICOSTEROID ACTION, 1994, 746 : 463 - 466
12345